Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Start Date Set For Bundling, Gainsharing Program For Hip, Knee Implants

This article was originally published in The Gray Sheet

Executive Summary

CMS gave hospitals and other providers more time to prepare for an expanding bundled payment program targeting hip and knee implant procedures, moving a proposed Jan. 1 start date to April.

You may also be interested in...



Boston Scientific Thinks Big In Heart Failure Risk-Share Plan

Value-based care and leveraging digital health and analytics are now viewed as the all-important ingredients in sustainable health care delivery. With that in mind, Boston Scientific and global professional services company Accenture recently joined forces in a total-cost-of-care heart failure project that is rewarded on patient outcomes.

Policy Briefs: What's New From FDA And CMS

Updates include an FDA safety communication for the Lariat suture device addressing use for left atrial appendage closure, new FDA draft guidance documents, and CMS proposals to cut radiation therapy payments and launch new payment models for hip and knee replacements.

Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines

Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034416

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel